Medico Remedies Limited (MEDICO.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-8.6%

₹17.29

vs ₹18.92 price

Levered DCF

₹4.73

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

—

Rating

B-

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	20.73×	43.69×	49.45×	86.26×	41.72×	78.06×	121×	127.37×
P/B	3.6×	7.06×	7.83×	14.21×	5.4×	6.19×	6.72×	7.11×
P/S	1.32×	2.92×	2.83×	4.43×	1.66×	1.64×	2.27×	2.06×
EV / EBITDA	12.6×	30.3×	28.13×	46.56×	28.63×	40.66×	45.42×	49.23×
Gross margin	21.6%	28.2%	12.1%	25.3%	14.6%	19.1%	17.3%	12.6%
Operating margin	6.8%	24.1%	7.0%	5.0%	4.3%	2.9%	1.4%	1.3%
Net margin	6.4%	6.7%	5.7%	5.2%	4.0%	2.1%	1.8%	1.6%
Current ratio	1.66×	1.7×	1.72×	1.55×	1.51×	1.54×	1.4×	1.3×
Debt / equity	0.25×	0.24×	0.15×	0.22×	0.34×	0.46×	0.46×	0.48×
Interest coverage	7.71×	31.36×	12.34×	9.35×	8.25×	3.91×	1.14×	1.28×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	17.4%	16.2%	15.8%	16.5%	12.9%	8.0%	5.5%	5.6%
Return on invested capital	10.7%	35.2%	12.3%	9.3%	7.9%	5.3%	2.0%	2.2%
Return on assets	8.5%	8.4%	8.6%	8.3%	6.2%	3.4%	2.2%	2.1%
Free cash flow yield	-1.3%	0.4%	0.0%	0.3%	-0.6%	0.2%	-1.2%	0.6%
Earnings yield	4.8%	2.3%	2.0%	1.2%	2.4%	1.3%	0.8%	0.8%
Enterprise value	₹2.9B	₹4.5B	₹4.2B	₹6.3B	₹2.1B	₹2.1B	₹2.1B	₹2.1B
Net debt / EBITDA	0.75×	0.91×	0.53×	0.65×	1.54×	2.33×	2.81×	3.07×
Cash conversion cycle (days)	101	111	82	55	61	42	75	47